If you didn’t grow up on the Internet, or you have some sort of Real Job (TM) that keeps you away from the Internet for vast stretches of time during which you actually interact with your fellow human beings, you may be unfamiliar with Godwin’s Law, which states “As an online discussion grows longer, the […]
A note: I wrote these remarks after having watched the reception to my interview in The Atlantic about the need for women in futurism. A relevant snippet: Ashby says that any time she speaks in front of a crowd, and offers a grim view of the future, someone (almost always a man) invariably asks why […]
A while ago, I tweeted something based on this piece in VICE UK, called “Things You Only Know When You’ve Worked in Retail.” I don’t really care for the clickbaity title, but the content of the piece isn’t wrong. Here’s what I said: People ask me how I do gritty, lived-in SF and futures work […]
You’re probably tired of hearing me bang on about the Hieroglyph anthology. But one of the reasons I’ve talked about it and promoted it so tirelessly is because I had a great time participating in it. A large part of my enjoyment had to do with the talent, patience, and confidence of my editor, Kathryn […]
My next book, Company Town (which is currently available for pre-order), takes place on an oil rig on the Atlantic, 500km NE of St. John’s, Newfoundland. It’s my first book set in Canada, despite the fact that I moved to Toronto in 2006. Today being Canada Day, I thought I would talk about why I […]
I don’t recall the first time I donated to Planned Parenthood. It might have been online. It might have been on the street. I’m not sure. But I will always remember why.
Last year, I was nominated for a Campbell Award, for my debut novel vN. Then I declined the nomination, because I realized I wasn’t truly eligible for the award that year. Why? Because I’d already made a sale to Nature magazine. SFWA treats Nature as a Campbell-qualifying market, which means my “Campbell clock” (which I imagine […]
A while ago, I paid for a personal genomic saliva kit from 23andMe, a California firm that screens saliva samples for a variety of known genetic trouble spots. Recently, the FDA ordered 23andMe to stop marketing the testing kits, saying that the claims made by the marketing are not backed by science, making possible a […]